A move Down Under gave a big lift to a Canadian marijuana stock Monday. Here’s some small stocks making big moves on Monday, February 5, 2018 (as of 4 pm EST):
Cronos Group Inc. (TSXV:MJN), a Canadian marijuana stock, jumped 8% to $7.36 on Monday after announcing the launch of Cronos Australia Pty Ltd. and the grant of medicinal cannabis cultivation and research licenses.
As well, shares of NextSource Materials Inc. (TSX:NEXT) fell 13% to $0.13 as the graphite project developer said Oliver Peters will commission the Company’s Molo graphite mine in Madagascar and act as the Company’s principal process engineering consultant for Phase 1 of the Molo mine.
Agility Health, Inc. (TSXV:AHI), meanwhile, reported that it has signed a definitive agreement to sell 100% of its U.S.-based assets to Alliance Physical Therapy Management, LLC for US$45 million. Agility Health stock popped as much as 54% before dropping 23% to $0.05 following the announcement.
Finally, Tetra Bio-Pharma Inc. (TSXV:TBP) shares rose 7% to $1.09 after the provider of cannabinoid-based drug development and discovery announced that it has received a No Objection Letter from the Therapeutic Products Directorate Health Canada to its Clinical trial application for the Company’s PPP001 prescription smokable dried cannabis product.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
Cronos Group Inc. (TSXV:MJN), a Canadian marijuana stock, jumped 8% to $7.36 on Monday after announcing the launch of Cronos Australia Pty Ltd. and the grant of medicinal cannabis cultivation and research licenses.
